Dalteparin in critically ill patients.
作者信息
Esterbrook Georgina, Hart Simon
出版信息
N Engl J Med. 2011 Jul 14;365(2):179; author reply 180. doi: 10.1056/NEJMc1105423.
PMID:21751920
Abstract
摘要
相似文献
1
Dalteparin in critically ill patients.达肝素用于危重症患者。
N Engl J Med. 2011 Jul 14;365(2):179; author reply 180. doi: 10.1056/NEJMc1105423.
2
Dalteparin versus unfractionated heparin in critically ill patients.达肝素与普通肝素在危重症患者中的比较。
N Engl J Med. 2011 Apr 7;364(14):1305-14. doi: 10.1056/NEJMoa1014475. Epub 2011 Mar 22.
3
Dalteparin in critically ill patients.达肝素用于危重症患者。
N Engl J Med. 2011 Jul 14;365(2):179-80; author reply 180. doi: 10.1056/NEJMc1105423.
4
Dalteparin and heparin-induced thrombocytopenia.达肝素与肝素诱导的血小板减少症。
N Engl J Med. 2011 Sep 22;365(12):1158; author reply 1158. doi: 10.1056/NEJMc1108392.
5
Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.达肝素与未分级肝素预防危重症患者静脉血栓栓塞的成本效益比较。
JAMA. 2014 Nov 26;312(20):2135-45. doi: 10.1001/jama.2014.15101.
6
Cancer-associated thrombosis.癌症相关血栓形成
N Engl J Med. 2003 Jul 10;349(2):109-11. doi: 10.1056/NEJMp030086.
7
Risk assessment and prophylaxis of venous thromboembolism in acutely and/or critically ill patients.急重症患者静脉血栓栓塞症的风险评估与预防
Haemostasis. 2000;30 Suppl 2:77-81; discussion 63. doi: 10.1159/000054168.
8
PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan.重症监护预防血栓栓塞试验方案和分析计划。
J Crit Care. 2011 Apr;26(2):223.e1-9. doi: 10.1016/j.jcrc.2011.02.010.
9
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.达肝素预防急性内科疾病患者静脉血栓栓塞的随机、安慰剂对照试验。
Circulation. 2004 Aug 17;110(7):874-9. doi: 10.1161/01.CIR.0000138928.83266.24. Epub 2004 Aug 2.
10
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.低分子量肝素与香豆素类药物用于预防癌症患者复发性静脉血栓栓塞的比较
N Engl J Med. 2003 Jul 10;349(2):146-53. doi: 10.1056/NEJMoa025313.
Zotero 插件